| abstract |
(4-amino-3- (4-phenoxyphenyl) -1 H-pyrazolo [3,4-d] pyrimidin- 1 -yl) Piperidin-1-yl) prop-2-en-1-one are described herein. Also disclosed are methods of using Btk inhibitors, alone or in combination with other therapeutic agents, for the treatment of autoimmune diseases or conditions, heterologous immune diseases or conditions, cancers such as lymphoma, and inflammatory diseases or conditions. |